Literature DB >> 4051203

Effects of fentanyl and diazepam in dogs deprived of autonomic tone.

J W Flacke, L J Davis, W E Flacke, B C Bloor, A P Van Etten.   

Abstract

In contrast to reports of the untoward hemodynamic effects of fentanyl and diazepam in intact organisms, we found that neither a bolus of 100 micrograms/kg fentanyl nor the addition of intravenous doses of diazepam, up to and including 1 mg/kg (cumulative dose 2 mg/kg) caused cardiovascular depression in 13 anesthetized dogs after elimination of their sympathetic and parasympathetic tone. There were no significant changes in mean arterial blood pressure, cardiac output, heart rate, peak left ventricular dP/dt, cardiac filling pressures, or systemic vascular resistance. Rapid bolus injection of 3 mg/kg diazepam (cumulative dose 5 mg/kg) caused a significant (P less than 0.05) but transient (time to 50% recovery less than 2 min) decrease in systemic vascular resistance, blood pressure, and dP/dt. When corrected for pressure changed (dP/dt divided by simultaneous left ventricular pressure), the decrease in dP/dt did not attain statistical significance, nor did changes in cardiac output or filling pressures, even after this large dose of diazepam. We conclude that previously reported decreases in hemodynamic function in subjects with intact autonomic function after fentanyl alone, or after the combination of fentanyl and diazepam, are indirect in nature, that is, are caused by a centrally mediated decrease in vasoregulatory (mainly sympathetic) outflow from the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4051203

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  11 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Ability of pulse contour and esophageal Doppler to estimate rapid changes in stroke volume.

Authors:  Scott R Gunn; Hyung Kook Kim; Peter W J Harrigan; Michael R Pinsky
Journal:  Intensive Care Med       Date:  2006-07-28       Impact factor: 17.440

3.  Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine.

Authors:  C A Mills; J W Flacke; W E Flacke; B C Bloor; M D Liu
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

4.  Role of central and peripheral opioid receptors in the cardioprotection of intravenous morphine preconditioning.

Authors:  Y Lu; C Dong; J Yu; L Li
Journal:  Ir J Med Sci       Date:  2011-07-29       Impact factor: 1.568

5.  Low-dose fentanyl reduces pain perception, muscle sympathetic nerve activity responses, and blood pressure responses during the cold pressor test.

Authors:  Joseph C Watso; Mu Huang; Luke N Belval; Frank A Cimino; Caitlin P Jarrard; Joseph M Hendrix; Carmen Hinojosa-Laborde; Craig G Crandall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-12-01       Impact factor: 3.210

6.  Inhibitory effect of fentanyl on phenylephrine-induced contraction of the rat aorta.

Authors:  Kyeong-Eon Park; Ju-Tae Sohn; Young Seok Jeong; Hui-Jin Sung; Il-Woo Shin; Heon-Keun Lee; Young-Kyun Chung
Journal:  Yonsei Med J       Date:  2009-06-24       Impact factor: 2.759

Review 7.  Drug interactions of clinical significance with opioid analgesics.

Authors:  P M Maurer; R R Bartkowski
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

Review 8.  Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.

Authors:  T A Bowdle
Journal:  Drug Saf       Date:  1998-09       Impact factor: 5.606

9.  Sufentanil anaesthesia for major surgery: the multicentre Canadian clinical trial.

Authors:  J M Murkin
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

10.  Fentanyl pretreatment attenuates the haemodynamic response to sudden inhalation of 5% isoflurane.

Authors:  H Kinoshita; H Wakamatsu; Y Taira; K Ishida; A Yonei
Journal:  Can J Anaesth       Date:  1995-03       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.